SCHEDULE 13GAccepted Apr 1, 1:02 PM ET
Avalo Therapeutics, Inc. SCHEDULE 13G
Accepted (ET)
1:02 PM
Apr 1, 2026
Filed
Apr 1, 2026
Documents
2
Size
21.6 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.